Read + Share
Park S, Oh D, Choi YL, Chi SA, et al. Durvalumab and tremelimumab with definitive chemoradiotherapy for locally
advanced esophageal squamous cell carcinoma. Cancer 2022 Mar 23. doi: 10.1002/cncr.34176.
PMID: 35319779
|
 |
|
Park S, Oh D, Choi YL, Chi SA, et al. Durvalumab and tremelimumab with definitive chemoradiotherapy for locally
advanced esophageal squamous cell carcinoma. Cancer 2022 Mar 23. doi: 10.1002/cncr.34176.
PMID: 35319779
|
|
|
|